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Abstract
Background: Postoperative recurrence remains the major cause of death after curative resection for hepatocellular
carcinoma (HCC). This study was conducted to evaluate the impact of postoperative complications on HCC
recurrence after curative resection.
Methods: The postoperative outcomes of 274 HCC patients who underwent curative resection were analysed
retrospectively.
Results: Of the 247 HCC patients, 103 (37.6 %) patients developed postoperative complications. The occurrence of
postoperative complications was found to be associated with a significantly higher tumor recurrence (76.2 % vs. 56.6 %,
P = 0.002) and a lower 5-year overall survival rate (27.7 % vs. 42.1 %; P = 0.037) as compared with those without
complications. Regarding the recurrence pattern, early recurrence (≤2 years) was more frequently seen in patients with
complications than that in patients without complications (54.5 % vs.38.6 %; P = 0.011). Multivariate analysis indicated that
postoperative complications occurrence was an independent risk factor for early recurrence (odds ratio [OR] 2.223; 95 %
confidence intervals [95 % CI] 1.161–4.258, P = 0.016) and poor overall survival (OR 1.413; 95 % CI, 1.012–1.971, P = 0.042).
Conclusions: The results of the present study indicate that the occurrence of postoperative complications is a predictive
factor for HCC recurrence after curative hepatectomy, especially for early recurrence.
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Background
Hepatocellular carcinoma (HCC) is the 5th most com-
mon malignancy and ranks the 3rd cause of cancer-
related death worldwide. Although hepatic resection is
an effective treatment option for HCC, the long-term
prognosis remains poor in most series mainly because of
the high tumor recurrence in the remnant liver [1].
With improvements in careful patient selection, surgi-
cal techniques and perioperative care, hepatectomy for
HCC has become a safe procedure with a reported op-
erative mortality rate lower than 5 % at high-volume
centers. However, the incidence of complications is as
high as 30.9–42.6 % [2–4]. Several studies have assessed
the impact of postoperative complications on long-term
survival in patients with HCC [2, 5–7], but few data are
available in the literature regarding its impact on the risk
of tumor recurrence. To clarify this issue, we conducted
a retrospective study of 274 consecutive patients who
underwent curative resection for HCC.
Methods
Patients
Included in this study were 274 consecutive patients who
underwent curative resection for HCC at the Department
of Special Treatment of the Eastern Hepatobiliary Surgery
Hospital affiliated to the Second Military Medical
University (Shanghai, China) between January 2004
and September 2008. Curative resection was defined
as complete macroscopic removal of the tumor with a
microscopic free margin. Patient selection for hepa-
tectomy and details of hepatectomy were as previ-
ously reported [8]. A major resection was defined as
* Correspondence: yjm1952@sina.cn
†Equal contributors
2Department of Special Treatment, Eastern Hepatobiliary Surgery Hospital,
Second Military Medical University, Shanghai, China
Full list of author information is available at the end of the article
© 2015 Zhou et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Zhou et al. BMC Cancer  (2015) 15:689 
DOI 10.1186/s12885-015-1720-0
removal of at least three liver segments, and a minor resec-
tion was defined as removal of two or fewer than two seg-
ments. Postoperative mortality was defined as any death
occurring within 30 days of surgery or within the same
hospital stay. Postoperative complications were defined as
occurrence of any medical or surgical complication during
the hospital stay. Data for long-term outcomes, including
overall survival (OS) and recurrence, were obtained by
reviewing the medical records at the last follow-up. After
surgery, patients were followed-up every 1 month by
tumor marker (alpha-fetoprotein, AFP) analysis and ultra-
sound at least every 3 months in the first year after hepa-
tectomy, and then at gradually increasing intervals. When
tumor recurrence or metastases were suspected, further
investigations with computed tomography scan, or mag-
netic resonance imaging were done. Fine needle aspir-
ation/biopsies were done when necessary. Recurrences
were divided as early (≤2 years) and late (>2 years) recur-
rences [9]. This study was approved by the ethics commit-
tee of the Second Military Medical University, and all
participants provided written informed consent.
Statistical analysis
Categorical and continuous data were compared by the
χ2 test and the Student t test, respectively. Overall sur-
vival was determined by Kaplan-Meier analysis. The Cox
proportional hazard regression model was used to deter-
mine the independent risk factors for recurrence and
survival as well as complication, based on the variables
selected by univariate analysis. All statistical analyses
were performed using SPSS for Windows (version 11.0;




The 274 HCC patients included 253 (92.3 %) men and 21
(7.7 %) woman with a median age of 56 (range 21–87)
years. Of them, 103 (37.6 %) developed 169 postoperative
complications (Table 1), of which pleural effusion (18.9 %)
and ascites (12 %) were the most common complications.
One patient died of postoperative sepsis and another one
died of postoperative liver failure, giving an overall hos-
pital mortality rate of 0.8 %.
The clinicopathological characteristics of the patients
with and without postoperative complications are shown
in Table 2. The percentages of elderly patients and those
with larger tumors were significantly higher in the post-
operative complication group than those in the non-
complication group. Major resections were performed
more frequently in patients with postoperative complica-
tions. Similarly, those with postoperative complications
had a longer operation time, more intraoperative blood
loss and a greater blood transfusion requirement.
Patient recurrence and survival
During a median follow-up period of 38 months, 175
(64.3 %) patients (excluding the hospital deaths) experi-
enced intrahepatic recurrences by the end of the study
period. The initial management for the recurrences in-
cluded transarterial chemoembolization (n = 72), percu-
taneous ablation (n = 37), repeated resection (n = 28),
liver transplantation (n = 3), and conservative treatment
(n = 35). The frequency of HCC recurrence was 77
(76.2 %) in patients with postoperative complications
and 98 (56.6 %) in those without postoperative compli-
cations (P = 0.002). There were 121 early and 54 late re-
currences. Early recurrence was more frequently seen in
patients with postoperative complications than that in
patients without postoperative complications (54.5 %
vs.38.6 %; P = 0.011), while late recurrence was similar
between the two groups (22.8 % vs.18.1 %; P = 0.354).
Univariate analysis showed that significant risk factors
associated with early recurrence were serum AFP >
400 ng/mL, tumor diameter > 5 cm, the absence of
tumor capsules, vascular invasion, multiple tumors, an
advanced TNM stage, and occurrence of postoperative
complications. Multivariate analysis showed that postop-
erative complications were one of the independent fac-
tors (odds ratio [OR] 2.223; 95 % confidence intervals
[95 % CI] 1.161-4.258, P = 0.016) (Table 3).
The 5-year OS for the entire cohort of HCC patients
was 37 %, and the 5-year OS in patients who experienced
postoperative complications was significantly lower than
that in patients without complications (27.7 % vs. 42.1 %;
P = 0.037) (Fig. 1). Multivariate analysis demonstrated that
Table 1 Details of postoperative complications
Types of complications No. of patients (%)
Liver failure/insufficiency 14 (5.1)
Bile leak 5 (1.8)
Biloma/abscess 2 (0.7)
Intra-abdominal infection 5 (1.8)
Hemorrhage 4 (1.5)
Ascites 31 (12)
Wound infection/dehiscence 11 (4)




Heart failure 1 (0..3)
Urinary retention 4 (1.5)
Urinary tract infection 3 (1.1)
Renal insufficiency/failure 3 (1.1)
Ileus 5 (1.8)
Delayed Gastric Emptying 3 (1.1)
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cirrhosis (OR 1.544; 95 % CI 1.051–2.269, P = 0.027), vas-
cular invasion (OR 2.712; 95 % CI, 1.371–5.364, P = 0.004),
and postoperative complications (OR 1.413; 95 % CI,
1.012–1.971, P = 0.042) were significant independent risk
factors for decreased OS.
Risk factor for postoperative complications
Univariate analysis showed that old age (≥70 years),
major resections, large tumor, blood transfusion, operating
time ≥ 300 min, and intraoperative blood loss ≥1000 ml
were associated with the occurrence of postoperative com-
plications. Multivariate analysis identified two independent
risks for complications occurrence: old age (OR 2.173;
95 % CI, 1.014–4.656, P = 0.046) and intraoperative blood
loss ≥1000 ml (OR 1.771; 95 % CI, 1.138–2.756, P = 0.011).
Discussion
Complications after hepatectomy for HCC are common
with morbidity rates between 30.9 and 42.6 % [2–4]. In
line with literature, a morbidity rate of 37.6 % was ob-
served in the present study. The most common were as-
cites or pleural effusion. The high incidence of ascites
Table 2 Comparison of clinicopathological features between patients with or without postoperative complication
Variable With complications (n = 103) Without complications (n = 171) P-value
Sex (male/female) 95/8 158/13 0.960
Age (years) 58.3 ± 11.2 54.7 ± 10.2 < 0.001
Hepatitis B infection 97 (94.2 %) 166 (97.1 %) 0.236
Hepatitis C infection 0 1 (0.6) 0.437
Child-Pugh (A/B) 98/5 168/3 0.140
AFP level > 400 ng/ml 27 (26.2 %) 31 (18.1 %) 0.113
Cirrhosis 41 (39.8 %) 76 (44.4 %) 0.452
Tumor diameter > 5 cm 73 (68.9 %) 77 (51.5 %) 0.005
Tumor number (St/Mt) 85/18 147/24 0.444
Tumor capsule absent 49 (47.6 %) 72 (42.1 %) 0.377
Vascular invasion 53 (51.5 %) 72 (42.1 %) 0.132
Edmondson’s grade (I-II/III-IV) 22/ 81 34/137 0.769
TNM stage (I-II/III) 61/42 115/56 0.179
Operative procedure (MAR/MIR) 59/44 76/95 0.040
Use of the Pringle’s maneuver 97 (94.2 %) 160 (93.6 %) 0.840
Operation time (min) 297 ± 113 256 ± 134 < 0.001
Intraoperative blood loss (ml) 840 ± 520 620 ± 470 < 0.001
Blood transfusion requirement 34 (33 %) 37 (21.6 %) 0.037
St single tumor, Mt multiple tumors, AFP alpha-fetoprotein, MAR major resection, MIR minor resection
Table 3 Multivariable analysis of risk factors for early recurrence






Tumor diameter > 5 cm 1.083 0.736–1.593 0.685
Tumor capsule absent 0.747 0.452–1.235 0.255
Vascular invasion 2.916 1.541–5.516 < 0.001
TNM stage (III) 1.353 0.962–1.902 0.082
Multiple tumors 1.204 1.011–1.433 0.037
Postoperative
complications
2.223 1.161–4.258 0.016 Fig. 1 Cumulative overall survival after surgical resection in patients
with and without postoperative complications
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was probably related to high portal pressure after liver
resection, which can trigger massive ascites by stimulat-
ing neurohormonal systems to promote renal water and
sodium resorption [10]. The changes generated by vas-
cular clamping and instruments working close to the
diaphragm during hepatectomy may increase the risk of
pleural effusion [11].
There is no doubt that postoperative complications
may lead to prolonged hospital stay and higher medical
costs. Recent evidence has suggested that postoperative
complications also have negative impact on long-term
survival in patients with gastric cancer [12], esophageal
cancer [13], pancreatic cancer [14], hilar cholangiocarci-
noma [15], and colorectal liver metastasis [16, 17]. To
the best of our knowledge, there have been four studies
on the effect of postoperative complications on the sur-
vival and prognosis of HCC patients. In a study of 863
HCC patients undergoing curative resection, Chok et al.
[5] found that the presence of postoperative complica-
tions was independently associated with poor OS. In an-
other study of 291 patients, Kusano et al. [2] reported
that the 5-year OS rate was significantly lower in pa-
tients with perioperative complications than that in
those without these complications (34.3 % vs.48.7 %).
Their multivariate analysis showed that the presence of
perioperative complications was an independent pre-
dictor of poor OS. A study of 100 patients by Mizuguchi
et al. [6], and a study of 376 patients by Okamura et al.
[7] also reported the similar results. Consistent with pre-
vious investigations, our study reconfirmed the prognos-
tic value of postoperative complications.
Few data are available in the literature regarding the
potential impact of complications on HCC recurrence. It
was found in this study that postoperative complications
were associated with a higher HCC recurrence after hep-
atectomy, and identified as an independent risk factor
for early recurrence. This finding is consistent with the
finding of Okamura et al. [7], who reported that the
recurrence-free survival curve for patients with postop-
erative complications was steeper than that for the
group without, especially from 12 to 24 months. Early
recurrence might reflect residual micrometastasis in the
liver [9]. In the field of periampullary cancer surgery, the
negative impact of postoperative complications on survival
is even more prominent in patients with microscopically
residual disease [18]. An explanation for negative impact
of postoperative complications on cancer recurrence re-
mains unclear. One possible factor promoting metastatic
growth and early recurrence is immunosuppression result-
ing from systemic inflammatory responses [16]. It has
been demonstrated that surgical trauma and septic in-
flammation may promote T-cell commitment toward a
T-helper 2-type lymphocyte pattern [19]. The T-helper
2-type cytokines (interleukin-10 in particular) were shown
to down-modulate tumor-specific immune response prob-
ably through several mechanisms: (i) directly suppressing
interferon γ and interleukin-12 production, thereby pre-
venting the activation of cytotoxic T lymphocytes and nat-
ural killer cells; (ii) reducing major histocompatibility
complex expression on the surface of tumor cells, thus
preventing the optimal expression of binary complexes
formed by tumor antigen in association with major histo-
compatibility complex molecules on the surface of such
cells; and (iii) inhibiting tumor antigen presentation by
antigen-presenting cells [20]. In fact, serum interleukin-10
level was found to be associated with a worse disease-free
survival in patients with resectable HCC [21]. As late re-
currence is considered as the most significant factor at-
tributable to hepatitis related multicentric carcinogenesis,
it is therefore reasonable to conclude that postoperative
complications have no effect on late recurrence.
Conventional aggressive biological behaviors of HCC
such as vascular invasion, poor tumor differentiation
and multiple tumors have been reported to affect recur-
rence. Our finding presented additional data that the
surgeon’s performance is also an important determinant.
Similar to other series [2], our study also found that in-
creased intraoperative blood loss was an independent
predictor of complications occurrence after hepatic re-
section for HCC. Various methods of vascular occlusion
(such as Pringle’s maneuver, total or selective hepatic
vascular exclusion, combination of Pringle’s maneuver
and infrahepatic inferior vena cava clamping, and hanging
maneuver) and new surgical devices (such as Harmonic
Scalpel, radiofrequency electrodes, and staplers) have been
suggested for reducing blood loss during liver parenchy-
mal transaction. Some recent studies [22] have suggested
that laparoscopic surgery for HCC can reduce intraopera-
tive blood loss without compromising the oncologic out-
come. Hepatic surgeons should know how to use these
surgical strategies appropriately according to the actual
situation in clinical practice.
Unlike previous findings [7], this study failed to show
that the use of Pringle’s maneuver is a risk factor for post-
operative complications. The main drawback related to
Pringle’s maneuver is the hepatic ischemia-reperfusion in-
jury. However, there is ample evidence that liver paren-
chyma tolerates prolonged ischemic injury better than the
effect of massive bleeding and blood transfusion [23].
More importantly, there is no clinical evidence that Prin-
gle’s maneuver adversely affects the oncologic outcome
[24]. To avoid irreversible injury to the liver, Pringle’s
maneuver should be done with intermittent clamping with
an upper limit of 120 min [23].
It was also found in our study that old age was a sig-
nificant risk factor for postoperative complications oc-
currence, probably because elderly patients are more
likely to have co-morbidities. This emphasizes the need
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of multidisciplinary preoperative evaluation and postop-
erative management of elderly patients undergoing hep-
atic resection [25].
There are several limitations in this study. First, its retro-
spective nature may inherently incur selection bias. In
addition, as this is a single-center study, the generalizability
of our findings awaits further investigation. Finally, the ef-
fect of classification of postoperative morbidity by the
Clavien-Dindo stratification was not analyzed because of
the limited number of patients [26]. Farid et al. [16] re-
ported a negative relationship between postoperative
morbidity and the oncologic outcome in 750 patients
undergoing hepatic resection for colorectal metastases.
Interestingly, the severity of complications was found
to be irrelevant to the oncologic outcome. A similar obser-
vation was also noted by Correa-Gallego et al. [17]. There-
fore, any postoperative complications (even minor ones)
need to be prevented for the sake of improving the
cancer-specific outcome [17].
Conclusion
The results of the present study indicate that the oc-
currence of postoperative complications is a predictive
factor for HCC recurrence after curative hepatectomy,
especially for early recurrence. To improve the pa-
tients’ oncological outcome, surgeons should do their
best to minimize the occurrence of postoperative
complications wherever possible. Further large pro-
spective multicenter clinical trials are necessary to
confirm our results.
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